Dave & Buster’s stock soars 28% after COVID-19 vaccine trial announcement

/ / News

Dave & Buster’s Entertainment Inc. stock soared 28.7% in Monday premarket trading after Pfizer Inc. and BioNTech SE announced a “successful” COVID-19 vaccine trial. Dave & Buster’s has struggled during the pandemic, with many locations still closed as of early October and September comparable sales down 62%. Dave & Buster’s stock has sunk by more than half in 2020, down 54%, while the S&P 500 index has gained 8.6% for the period.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.